Medical News

RSS

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

Epeius Biotechnologies Corporation today announces the clinical results of the study entitled "A Phase I/II Study of Intravenous Rexin-G and Reximmune-C for Cancer Immunotherapy: The GeneVieve Protocol" at the ASCO Annual Meeting on June 6, 2010. The presentation will be made by Dr. Jorge G. Ignacio, Chairman of the Cancer Institute and Bioethics Committee-Philippine General Hospital, and Principal Investigator of the study.

25 May 2010

DeCare Dental introduces International Emergency Dental Program

DeCare Dental, a global dental benefit management company and a wholly owned subsidiary of WellPoint, Inc., is pleased to introduce the International Emergency Dental Program – a service that gives dental members and their covered dependents access to emergency dental care from credentialed dentists around the world.

25 May 2010

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, today announced the completion of enrollment in a Phase 2a proof-of-concept trial for the treatment of impetigo.

25 May 2010

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Hawaii Pacific Health, Saint Barnabas Health Care System N.J., and XCelience LLC, have received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of these organizations to reducing the risk of cancer for employees and their families by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment.

25 May 2010

Researchers develop new device that can change current landscape of chronic wound management

Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease.

25 May 2010

AlphaMed Press earns CEO Cancer Gold Standard accreditation

AlphaMed Press has received CEO Cancer Gold Standard™ accreditation, recognizing the organization's commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

25 May 2010

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published in the May 2010 issue of Acta Anaesthesiologica Scandinavica shows that Masimo pleth variability index can be used to help clinicians assess risk for mean arterial pressure decreases and subsequent hypotension during anesthesia administration.

25 May 2010

USPTO issues composition of matter patent for Transave's ARIKACE

Transave Inc. today announced that the United States Patent and Trademark Office has issued an important composition of matter patent (U.S. Patent No. 7,718,189) for liposomal aminoglycoside formulations including its lead compound, ARIKACE™ (liposomal amikacin for inhalation). The company expects that the patent will provide exclusivity for ARIKACE until October 1, 2026.

25 May 2010

t2c001 product obtains certificate under EMA regulations for ATMPs

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the quality of its lead product t2c001 has been certified by the European Medicines Agency.

25 May 2010

Hospitalar Welch Allyn to feature electronic connected solutions for frontline caregivers in Latin America

Hospitalar—Welch Allyn, a leading global manufacturer of frontline medical products and solutions, is reconfirming its commitment to caregivers in Latin America with innovative solutions to healthcare issues that are unique to the region. In March 2009 the company acquired MD International (MDI), now Welch Allyn Latin America, and has since gained significant market share in South and Central America, Mexico and the Caribbean thanks to strong relationships with large distribution and manufacturer partners.

25 May 2010

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Vical Incorporated announced today that the company is collaborating with leading pediatric infectious disease researchers Stuart P. Adler, M.D., and Michael A. McVoy, Ph.D., of Virginia Commonwealth University under a five-year, approximately $4.0 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

25 May 2010

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.

25 May 2010

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

A new animal study has found that high levels of the B-vitamin folate (folic acid) prevented heart birth defects induced by alcohol exposure in early pregnancy, a condition known as fetal alcohol syndrome.

25 May 2010

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.

25 May 2010

USANA Health Sciences to enter China

USANA Health Sciences, Inc. announced that China will be its next international market. Over 6,000 USANA Associates and guests were in attendance at USANA's Asia Pacific Convention in Hong Kong to hear the announcement. This announcement was also broadcast live via a world-wide webcast to an additional 6,000 Associates in various USANA markets.

25 May 2010

Anti-aging supplements may prevent decline in physical function: Researchers

Anti-aging supplements made up of mixtures might be better than single compounds at preventing decline in physical function, according to researchers at the University of Florida's Institute on Aging. In addition, it appears that such so-called neutraceuticals should be taken before very old age for benefits such as improvement in physical function.

25 May 2010

Shrink files patent related to rapid prototyping system for manufacture of Lab-on-a-Chip devices

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors, and biotechnology research and development tools businesses, announced today that patent applications related to its rapid prototyping system for the manufacture of microfluidic chips, or Lab-on-a-Chip (LOC) devices, have been filed.

25 May 2010

Researchers use zebrafish as model to analyze function of every known mutation in BBS

A research team led by scientists from the Duke University Medical Center has developed a way to simultaneously look at the effects of 125 mutations occurring on 14 different genes. They used zebrafish as a model to analyze the function of every known mutation in an inherited syndrome called BBS, Bardet-Biedl Syndrome.

25 May 2010

Agilent Technologies, Stemina Biomarker Discovery to accelerate metobolomic research

Agilent Technologies Inc. and Stemina Biomarker Discovery, Inc. today announced efforts to accelerate Stemina's metobolomic research. Stemina uses metabolomic analysis of stem cells for the discovery of biomarkers for use in drug screening and drug development.

25 May 2010

EHSI reports favorable completion of due diligence with Stand-By Systems

Emerging Healthcare Solutions, Inc. disclosed today that the Company has just favorably completed the financial review phase of due diligence with Stand-By Systems. EHSI recently executed an option with Stand-By Systems; owner of the new FDA approved SBS 1615 catalytic oxygen generator, as well as the associated LIFEDGE® and MAYDAY® emergency systems. EHSI is currently performing due diligence under this option.

25 May 2010

Medical News

Epeius Biotechnologies announces Phase I/II study results of Rexin-G and Reximmune-C for cancer immunotherapy

DeCare Dental introduces International Emergency Dental Program

NovaBay Pharmaceuticals completes enrollment in Phase 2a trial of NVC-422 for treatment of impetigo

Hawaii Pacific Health, Saint Barnabas Health Care System and XCelience achieve CEO Cancer Gold Standard

Researchers develop new device that can change current landscape of chronic wound management

AlphaMed Press earns CEO Cancer Gold Standard accreditation

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

USPTO issues composition of matter patent for Transave's ARIKACE

t2c001 product obtains certificate under EMA regulations for ATMPs

Hospitalar Welch Allyn to feature electronic connected solutions for frontline caregivers in Latin America

Vical receives $4.0M grant to support development of novel vaccine for CMV infection

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

USANA Health Sciences to enter China

Anti-aging supplements may prevent decline in physical function: Researchers

Shrink files patent related to rapid prototyping system for manufacture of Lab-on-a-Chip devices

Researchers use zebrafish as model to analyze function of every known mutation in BBS

Agilent Technologies, Stemina Biomarker Discovery to accelerate metobolomic research

EHSI reports favorable completion of due diligence with Stand-By Systems

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News